The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
LY341495 is a nanomolar potent and selective antagonist of group II metabotropic glutamate receptors
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hollmann, M., & Heinemann, S. (1994) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.17.030194.000335 · Cited by 3,975
The metabotropic glutamate receptors: Structure and functions
Pin, J.-P., & Duvoisin, R. (1995) · Neuropharmacology · doi:10.1016/0028-3908(94)00129-g · Cited by 2,266
Storck, T., Schulte, S., Hofmann, K., & Stoffel, W. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.22.10955 · Cited by 1,183
Neurotransmitter receptor binding
Yamamura, H. I., Enna, S. J., & Kuhar, M. J. (1978) · Raven Press eBooks · Cited by 828
Metabotropic glutamate receptors in brain function and pathology
Schoepp, D. D., & Conn, P. J. (1993) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(93)90107-u · Cited by 791
Self-citationHayashi, Y., Sekiyama, N., Nakanishi, S., Jane, D., Sunter, D., Birse, E., Udvarhelyi, P., & Watkins, J. (1994) · The Journal of Neuroscience · doi:10.1523/jneurosci.14-05-03370.1994 · Cited by 320
Metabotropic Glutamate Receptors: Novel Targets for Drug Development
Knoepfel, T., Kuhn, R., & Allgeier, H. (1995) · Journal of Medicinal Chemistry · doi:10.1021/jm00009a001 · Cited by 260
SCHOEPP, D. D., JOHNSON, B. G., WRIGHT, R. A., SALHOFF, C. R., MAYNE, N. G., WU, S., COCKERHAM, S. L., PAUL BURNETT, J., BELEGAJE, R., BLEAKMAN, D., et al. (1997) · Neuropharmacology · doi:10.1016/s0028-3908(96)00160-8 · Cited by 225
Self-citationSaugstad, J. A., Kinzie, J. M., Shinohara, M. M., Segerson, T. P., & Westbrook, G. L. (1997) · Molecular Pharmacology · doi:10.1124/mol.51.1.119 · Cited by 205
Pellicciari, R., Raimondo, M., Marinozzi, M., Natalini, B., Costantino, G., & Thomsen, C. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm960254o · Cited by 202
Cited by
Ionotropic and metabotropic glutamate receptor structure and pharmacology
Kew, J. N. C., & Kemp, J. A. (2005) · Psychopharmacology · doi:10.1007/s00213-005-2200-z · Cited by 788
McBride, S. M. J., Choi, C. H., Wang, Y., Liebelt, D., Braunstein, E., Ferreiro, D., Sehgal, A., Siwicki, K. K., Dockendorff, T. C., Nguyen, H. T., et al. (2005) · Neuron · doi:10.1016/j.neuron.2005.01.038 · Cited by 472
Wang, Q., Walsh, D. M., Rowan, M. J., Selkoe, D. J., & Anwyl, R. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.1633-03.2004 · Cited by 437
Marek, G. J., Wright, R. A., Schoepp, D. D., Monn, J. A., & Aghajanian, G. K. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35262-0 · Cited by 280
Self-citationmTOR activation is required for the antidepressant effects of mGluR2/3 blockade
Dwyer, J. M., Lepack, A. E., & Duman, R. S. (2012) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711001702 · Cited by 169
Metadata
- Authors
- Kingston, A. E., Ornstein, P. L., Wright, R. A., Johnson, B. G., Mayne, N. G., Burnett, J. P., Belagaje, R., Wu, S., & Schoepp, D. D.
- Venue
- Neuropharmacology
- Publisher
- Elsevier BV
- Published
- 1998-01
- Volume
- 37
- Issue
- 1
- Pages
- 1-12
- ISSN
- 0028-3908 (ISSN-L)
- OpenAlex
- W2029542833
- Cited by
- 368
- References
- 26
- FWCI
- 5.35
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: LY341495 is a nanomolar potent and selective antagonist of group II metabotropic glutamate receptors. https://app.cochat.ai/papers/10.1016/s0028-3908(97)00191-3
- The paper
- Kingston, A. E., Ornstein, P. L., Wright, R. A., Johnson, B. G., Mayne, N. G., Burnett, J. P., Belagaje, R., Wu, S., & Schoepp, D. D. (1998). LY341495 is a nanomolar potent and selective antagonist of group II metabotropic glutamate receptors. Neuropharmacology. https://doi.org/10.1016/s0028-3908(97)00191-3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
